|
ASB7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.64155364249063E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.79709979809229E-10 |
| Normal-vs-Stage2 |
5.92549999999248E-05 |
| Normal-vs-Stage3 |
2.81480394548339E-11 |
| Normal-vs-Stage4 |
1.4641954315664E-11 |
| Stage1-vs-Stage2 |
7.521600E-01 |
| Stage1-vs-Stage3 |
3.569700E-02 |
| Stage1-vs-Stage4 |
8.360300E-04 |
| Stage2-vs-Stage3 |
9.174000E-02 |
| Stage2-vs-Stage4 |
1.263990E-02 |
| Stage3-vs-Stage4 |
2.125000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.47308856621476E-13 |
| Normal-vs-AfricanAmerican |
9.84910000000339E-05 |
| Normal-vs-Asian |
1.86650000000288E-06 |
| Caucasian-vs-AfricanAmerican |
7.544000E-01 |
| Caucasian-vs-Asian |
5.373200E-01 |
| AfricanAmerican-vs-Asian |
8.899600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.87250001562711E-09 |
| Normal-vs-Female |
4.7276627057613E-12 |
| Male-vs-Female |
7.360400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.67170002472051E-09 |
| Normal-vs-Age(41-60Yrs) |
3.57459950528494E-10 |
| Normal-vs-Age(61-80Yrs) |
1.44489975539841E-11 |
| Normal-vs-Age(81-100Yrs) |
3.398900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.778800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.167700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.676800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.133600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.257600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.868800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.615900E-02 |
| Classical-VS-Follicular |
9.591000E-01 |
| Classical-VS-Other |
5.202000E-01 |
| Classical-VS-Normal |
1.31540000003483E-07 |
| Tall-VS-Follicular |
3.898400E-02 |
| Tall-VS-Other |
6.111000E-01 |
| Tall-VS-Normal |
3.9806999918568E-09 |
| Follicular-VS-Other |
6.047400E-01 |
| Follicular-VS-Normal |
1.12409999997176E-06 |
| Other-VS-Normal |
8.300600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.40540032336867E-10 |
| Normal-vs-N1 |
1.84060000574249E-09 |
| N0-vs-N1 |
1.509220E-01 |
|
|
